A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- Pfizer
- Study ID
- NCT07575932
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Body Weight
- Nutrition Disorders
- Nutritional and Metabolic Diseases
- Obesity
- Overnutrition
- Overweight
- Overweight and/or Obesity
- Overweight or Obesity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- PF-08653945 — DRUGSubcutaneous Injection
- PF-08653944 — DRUGSubcutaneous Injection
- Placebo — DRUGSubcutaneous Injection
Study Details
This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weight loss, compared to a placebo (a dummy drug that has no active ingredient in it).
Key Dates
- Start date
- May 11, 2026
- Status verified
- Jun 2026
- Primary completion
- Aug 4, 2027
- Completion
- Jan 5, 2028
Study Design
- Enrollment
- 872 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Cohort 1Participants receive subcutaneous injections of PF-08653945 or placebo.
- Experimental: Cohort 2Participants receive subcutaneous injections of PF-08653945 + PF-08653944 or placebo.
- Experimental: Cohort 3Participants receive subcutaneous injections of PF-08653945 + PF-08653944 , PF-08653944 , or placebo.
Primary Outcome Measure
Percent change from baseline in body weight [ Time Frame: Baseline (Week 0) to Week 48 ]
Central Contacts
- Pfizer CT.gov Call Center1-800-718-1021
Locations (48)
Find similar trials in Chandler, AZ
By condition
By specialty
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Physical and Behavioral Traits of Overweight and Obese AdultsRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss TreatmentPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Phoenix, Arizona
- Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular SystemRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Washington D.C., District of Columbia